Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Archives of Internal Medicine|February 1, 1990
Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group IE Stein, R Kreisberg, V Miller, et al.Clinical Therapeutics|March 1, 1995
Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study GroupA E Sweany, D R Shapiro, A C Tate, et al.The American Journal of Cardiology|November 1, 1991
Long-term safety and efficacy profile of simvastatinS J Boccuzzi, T S Bocanegra, J F Walker, et al.Clinical Therapeutics|September 11, 1992
Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study ParticipantsJ A Farmer, L C Washington, P H Jones, et al.Metabolism: Clinical and Experimental|January 26, 2000
Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patientsA S Dobs, S Miller, G Neri, et al.The American Journal of Cardiology|August 1, 1997
Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)J R Downs, P A Beere, E Whitney, et al.JAMA|June 5, 1998
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention StudyJ R Downs, M Clearfield, S Weis, et al.Journal of Women'S Health & Gender-Based Medicine|January 15, 2002
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in womenM Clearfield, J R Downs, S Weis, et al.The American Journal of Cardiology|May 12, 2001
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatinJ R Downs, M Clearfield, H A Tyroler, et al.JAMA|April 9, 1997
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study GroupsD B Karpf, D R Shapiro, E Seeman, et al.Pageof 4